Department of Cardiology, Martini Hospital, Groningen, the Netherlands.
Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
JACC Cardiovasc Interv. 2014 Nov;7(11):1227-34. doi: 10.1016/j.jcin.2014.05.023. Epub 2014 Oct 15.
This study compared alcohol septal ablation (ASA) and surgical myectomy for periprocedural complications and long-term clinical outcome in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Debate remains whether ASA is equally effective and safe compared with myectomy.
All procedures performed between 1981 and 2010 were evaluated for periprocedural complications and long-term clinical outcome. The primary endpoint was all-cause mortality; secondary endpoints consisted of annual cardiac mortality, New York Heart Association functional class, rehospitalization for heart failure, reintervention, cerebrovascular accident, and myocardial infarction.
A total of 161 patients after ASA and 102 patients after myectomy were compared during a maximal follow-up period of 11 years. The periprocedural (30-day) complication frequency after ASA was lower compared with myectomy (14% vs. 27%, p = 0.006), and median duration of in-hospital stay was shorter (5 days [interquartle range (IQR): 4 to 6 days] vs. 9 days [IQR: 6 to 12 days], p < 0.001). After ASA, provoked gradients were higher compared with myectomy (19 [IQR: 10 to 42] vs. 10 [IQR: 7 to 13], p < 0.001). After multivariate analysis, age (per 5 years) (hazard ratio: 1.34 [95% confidence interval: 1.08 to 1.65], p = 0.007) was the only independent predictor for all-cause mortality. Annual cardiac mortality after ASA and myectomy was comparable (0.7% vs. 1.4%, p = 0.15). During follow-up, no significant differences were found in symptomatic status, rehospitalization for heart failure, reintervention, cerebrovascular accident, or myocardial infarction between both groups.
Survival and clinical outcome were good and comparable after ASA and myectomy. More periprocedural complications and longer duration of hospital stay after myectomy were offset by higher gradients after ASA.
本研究比较了酒精室间隔消融术(ASA)和手术心肌切除术治疗有症状肥厚型梗阻性心肌病患者围手术期并发症和长期临床结局。
目前仍存在争议,即 ASA 是否与心肌切除术同样有效和安全。
评估了 1981 年至 2010 年间所有进行的手术的围手术期并发症和长期临床结局。主要终点为全因死亡率;次要终点包括年度心脏死亡率、纽约心脏协会功能分级、因心力衰竭再住院、再介入、脑血管意外和心肌梗死。
在 11 年的最大随访期间,比较了 161 例 ASA 后患者和 102 例心肌切除术后患者。ASA 后围手术期(30 天)并发症发生率低于心肌切除术(14%比 27%,p=0.006),住院时间中位数更短(5 天[四分位距(IQR):4 至 6 天]比 9 天[IQR:6 至 12 天],p<0.001)。ASA 后,诱发的梯度高于心肌切除术(19[IQR:10 至 42]比 10[IQR:7 至 13],p<0.001)。多变量分析后,年龄(每增加 5 年)(危险比:1.34[95%置信区间:1.08 至 1.65],p=0.007)是全因死亡率的唯一独立预测因素。ASA 和心肌切除术的年度心脏死亡率相似(0.7%比 1.4%,p=0.15)。随访期间,两组在症状状态、因心力衰竭再住院、再介入、脑血管意外或心肌梗死方面无显著差异。
ASA 和心肌切除术的生存率和临床结局良好且相似。心肌切除术围手术期并发症更多,住院时间更长,但 ASA 后梯度更高,抵消了这一差异。